Polymyxin E, Colistin

Ceftobiprole medocaril

Effect of ECMO Minimal impact on drug PK
Dose recommendation ECMO-specific dose adjustment not required
Comments, reference Retrospective study, 28 patients on ECMO (Int J Antimicrob Agents 2023;61:106765).

An unhandled error has occurred. Reload 🗙

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please reload the page.